Low-concentration atropine can slow down the rate of myopia progression to a certain extent, and cannot completely control the degree of non-increase.
With the increasing prevalence of myopia in China, people pay more and more attention to the control of myopia, and low-concentration atropine is one of the hottest medicines researched and used in myopia population in recent years.
Low-concentration atropine is more effective than atropine, with fewer side effects, and has become more and more widely used in clinical practice.
Clinical use of low concentration atropine is mostly 0.01% and 0.05%, studies have shown that its use can effectively delay myopic eye axis growth, the mechanism is not very clear, may be related to its impact on scleral remodeling, reduce the growth of vitreous cavity, and the safety of which has also been recognized.
Therefore, low concentration of atropine can effectively slow down the growth of myopia, but can not make myopia not to grow at all, the specific can be used, but also need to go to the hospital to do the relevant examination under the guidance of the doctor to apply.